Speakers
Anders Bendsen Spohr
Session
This exclusive, invite-only breakfast convenes investors who are active in, or exploring, biosolutions for a focused discussion on the trends, opportunities and challenges shaping investment in the sector.
The session will open with a presentation of the BIA’s analysis of finance and investment trends across UK biosolutions companies. This will be followed by remarks from a leading investor, offering insight into how potential is currently being assessed and valued. The session will then move into an informal discussion over coffee and croissants, creating space for candid exchange among peers financing the sector.
Anders joined Novo Holdings A/S in 2017.
Anders is Managing Partner and Head of the Planetary Health Investments team.
Prior to joining Novo Holdings, Anders was employed as VP in Xellia Pharmaceuticals heading up the Global Product Supply. Other previous employments include EVP, Global Product Supply at Leo Pharma A/S and VP Global Supply Chain at Novozymes A/S.
Anders holds a PhD in Biotechnology and a MSc in Chemical Engineering from Technical University of Denmark as well as a graduate diploma in Business Administration (International Business) from Copenhagen Business School.
As a Data Insights Executive, Wendy specialises in gathering and analysing data across the UK and global biotech sectors. Her work revolves around turning complex datasets into clear, actionable insights that support strategic areas within the BIA. She translates data into intuitive visualizations and reports, allowing key stakeholders and the biotech community to easily understand market trends, research developments and stay ahead in a rapidly evolving landscape.
Wendy managed laboratory operations at Randox Health, where she used statistical software to analyse data and provide meaningful insights.
As an IT Business Analyst, Wendy facilitated effective communication between stakeholders and technical teams, guiding projects from planning to deployment. Additionally, she managed vendor relations, ensuring clear deliverables and adherence to project timelines.
Wendy has a BSc in Biomedical Science from Coventry University and an MBA in Business Analytics from the University of East London. Wendy has also received Microsoft-accredited AZ-900 and DP-900 certifications, demonstrating her knowledge in key data principles and databases.